Oliver Van Oekelen
About Me
Oliver Van Oekelen holds a MD from the University of Leuven in Belgium and a PhD in Biomedical Sciences from the Icahn School of Medicine at Mount Sinai. He completed two years of Internal Medicine residency in Belgium before undertaking his PhD studies and is now doing a residency in Internal Medicine at Icahn Mount Sinai.
Dr. Van Oekelen has a broad interest in transitional biomedical research in immunology and oncology with a focus on bioinformatics and medical informatics approaches. In the laboratory of Samir Parekh, MBBS, he is conducting research on multiple myeloma, investigating the role of the bone marrow microenvironment on disease development, progression, and relapse. He is using next generation sequencing at the single-cell level and mass cytometry to decipher the crosstalk between various cell types in the bone marrow microenvironment.
Dr. Van Oekelen was selected by the American Society of Hematology to receive a 2024 Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award.
Language
English
Position
PGY-4S(CF) | Medicine, Hematology and Medical Oncology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. VAN OEKELEN has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.